Guideline for Reversal of Antithrombotics in Intracranial Hemorrhage: Executive Summary. A Statement for Healthcare Professionals From the Neurocritical Care Society and the Society of Critical Care Medicine.

Frontera, Jennifer A; Lewin, John J; Rabinstein, Alejandro A; Aisiku, Imo P; Alexandrov, Anne W; Cook, Aaron M; Del Zoppo, Gregory J; Kumar, Monisha; Peerschke, Ellinor I B; Stiefel, Michael F; Teitelbaum, Jeanne S; Wartenberg, Katja E; Zerfoss, Cindy L

Frontera, Jennifer A; Lewin, John J; Rabinstein, Alejandro A; Aisiku, Imo P; Alexandrov, Anne W; Cook, Aaron M; Del Zoppo, Gregory J; Kumar, Monisha; Peerschke, Ellinor I B; Stiefel, Michael F; Teitelbaum, Jeanne S; Wartenberg, Katja E; Zerfoss, Cindy L.

Affiliation

Frontera JA; 1The Cerebrovascular Center, Neurological Institute, Cleveland Clinic and Case Western Reserve University, Cleveland, OH.2The Departments of Pharmacy and Anesthesiology & Critical Care Medicine, The Johns Hopkins Hospital and Johns Hopkins University School of Medicine, Baltimore, MD.3The Department of Neurology, Mayo Clinic, Rochester, MN.4Department of Emergency Medicine, Harvard Medical School, Brigham and Women's Hospital, Boston, MA.5The University of Tennessee Health Science Center, Me

Crit Care Med ; 44(12): 2251-2257, 2016 12.

Article in En | MEDLINE | ID: mdl-27858808

Subject(s)

Critical Care/standards; Fibrinolytic Agents/therapeutic use; Intracranial Hemorrhages/prevention & control; Neurology/standards; Fibrinolytic Agents/adverse effects; Humans; Intracranial Hemorrhages/chemically induced; Secondary Prevention/methods; Societies, Medical/standards; Thromboembolism/drug therapy; United States

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Intracranial Hemorrhages / Critical Care / Fibrinolytic Agents / Neurology Type of study: Guideline Limits: Humans Country/Region as subject: America do norte Language: En Journal: Crit Care Med Year: 2016 Type: Article

Search on Google

XML

PubMed Links